HKD 3.2
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 378.36 Million CNY | -52.56% |
2022 | 976.56 Million CNY | 86.63% |
2021 | 523.26 Million CNY | 45.82% |
2020 | 358.84 Million CNY | 4.69% |
2019 | 342.75 Million HKD | 2.66% |
2018 | 333.88 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 127.73 Million HKD | -9.8% |
2024 Q2 | 126.64 Million HKD | -0.15% |
2023 Q2 | 62.53 Million HKD | -5.52% |
2023 Q3 | 140.8 Million HKD | 125.17% |
2023 FY | 463.31 Million CNY | -52.56% |
2023 Q4 | 144.42 Million HKD | 2.57% |
2023 Q1 | 66.18 Million HKD | -75.93% |
2022 Q3 | 268.04 Million HKD | -39.78% |
2022 FY | 976.56 Million CNY | 86.63% |
2022 Q4 | 274.94 Million HKD | 2.58% |
2022 Q2 | 445.12 Million HKD | 0.0% |
2021 FY | 523.26 Million CNY | 45.82% |
2020 FY | 358.84 Million CNY | 4.69% |
2019 FY | 342.75 Million HKD | 2.66% |
2018 FY | 333.88 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Life Healthcare Group Limited | 20.15 Million HKD | -1777.261% |
China Biotech Services Holdings Limited | 161.99 Million HKD | -133.56% |